Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INV-102 in Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
NCT06599684Phase 2Completed
- Sponsor
- Invirsa
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of INV-102 in diabetic macular edema (DME), diabetic retinopathy (DR), sponsored by Invirsa. Started Sep 2024; status: completed.
02
Drugs
INV-102
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT06599684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06599684.